2014 – FDA requires testosterone manufacturers to include a warning about health risks, including pulmonary embolism.
2014 – FDA requires warning
Announcement Date: February 1, 2014
2014 – FDA requires testosterone manufacturers to include a warning about health risks, including pulmonary embolism.